Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial (Q38969496)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

traumatic brain injury

0 references

botulinum toxin type A

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

François Boyer

0 references

author name string

Jean-Michel Gracies

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Allison Brashear

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Robert Jech

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Peter McAllister

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Marta Banach

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Peter Valkovic

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Heather Walker

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Christina Marciniak

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Thierry Deltombe

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Alexander Skoromets

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Svetlana Khatkova

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Steven Edgley

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Fatma Gul

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

France Catus

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Beatrice Bois De Fer

15

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Claire Vilain

16

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Philippe Picaut

17

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group

18

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

26 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

992-1001

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Pathophysiology of spastic paresis. I: Paresis and soft tissue changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of spastic paresis. II: Emergence of muscle overactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

European consensus table on the use of botulinum toxin type A in adult spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and Safety of Botulinum Neurotoxin NT 201 in Poststroke Upper Limb Spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrocnemius Muscle Contracture After Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Does reducing spasticity translate into functional benefit? An exploratory meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between impairment and motor performance during reaching tasks in subjects with spastic hemiparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Tardieu Scale differentiates contracture from spasticity whereas the Ashworth Scale is confounded by it

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation between Ashworth scores and neuromechanical measurements of spasticity following stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2815%2900216-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(15)00216-1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38969496&oldid=1980122560"